Atlas FDA

Edwards SAPIEN XT Transcatheter Heart Valve

FDA premarket approval P130009/S105 · decided 2020-04-10

Approval details

PMA number
P130009
Supplement
S105
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Edwards SAPIEN XT Transcatheter Heart Valve
Generic name
Aortic valve, prosthesis, percutaneously delivered
Applicant
Edwards Lifesciences, LLC
Date received
2019-11-18
Decision date
2020-04-10
Days to decision
144 days
Decision code
APPR
Product code
NPT
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
Approval for a manufacturing site located at Edwards Lifesciences (Singapore) Pte. Ltd, 35 Changi North Crescent, Singapore 499641 SG, to receive and process bovine pericardial tissue sacs into treated tissue heart valve leaflets.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Respiration Rate algorithm (K251326)Edwards Lifesciences, LLC2026-06-11
HemoSphere Nano Monitor (HSNANO1) (K253186)Edwards Lifesciences, LLC2026-02-24
Edwards MC3 Tricuspid annuloplasty ring (4900) (K251982)Edwards Lifesciences, LLC2025-09-23
Carpentier-Edwards Physio Annuloplasty Ring (4450) (K251688)Edwards Lifesciences, LLC2025-09-17
Hypertension Prediction Index (HePI) Algorithm (K242518)Edwards Lifesciences, LLC2025-05-15
FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors (K242909)Edwards Lifesciences, LLC2025-03-21
Fogarty Thru-Lumen Embolectomy Catheter (K240078)Edwards Lifesciences, LLC2024-08-28
Acumen Assisted Fluid Management (AFM) Software Feature (K233984)Edwards Lifesciences, LLC2024-08-02